References
- Boxer LA. How to approach neutropenia. Hematology Am Soc Hematol Educ
Program, 2012; 2012: 174-182.
- Andrès E, Maloisel F, Kurtz JE, Kaltenbach G, Alt M, Weber JC, Sibilia
J, Schlienger JL, Blicklé JF, Brogard JM, Dufour P. Modern management
of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort
study of 90 cases and review of the literature. Eur J Intern Med.
2002; 13: 324-328.
- Mijovic A, MacCabe JH. Clozapine-induced agranulocytosis. Ann Hematol.
2020; 99: 2477-2482.
- Genchanok Y, Tolu SS, Wang H, Arora S. Agranulocytosis from Outpatient
Antimicrobial Treatment with Ceftriaxone: A Case Report. Perm J. 2019;
23: 18-190.
- Weitzman SA, Stossel TP. Drug-induced immunological neutropenia.
Lancet. 1978; 1: 1068-1072.
- Olaison L, Belin L, Hogevik H, Alestig K. Incidence of
beta-lactam-induced delayed hypersensitivity and neutropenia during
treatment of infective endocarditis. Arch Intern Med. 1999; 159:
607-615.
- Noguchi Y, Ueno A, Otsubo M, Katsuno H, Sugita I, Kanematsu Y, Yoshida
A, Esaki H, Tachi T, Teramachi H. A simple method for exploring
adverse drug events in patients with different primary diseases using
spontaneous reporting system. BMC Bioinformatics. 2018; 19: 124.
- Hashiguchi M, Imai S, Uehara K, Maruyama J, Shimizu M, Mochizuki M.
Factors Affecting the Timing of Signal Detection of Adverse Drug
Reactions. PLoS One. 2015; 10: e0144263.
- Sauzet O, Carvajal A, Escudero A, Molokhia M, Cornelius VR.
Illustration of the weibull shape parameter signal detection tool
using electronic healthcare record data. Drug Saf. 2013; 36: 995-1006.
- Kotani A, Hirai J, Hamada Y, Fujita J, Hakamata H. Determination of
ceftriaxone concentration in human cerebrospinal fluid by
high-performance liquid chromatography with UV detection. J Chromatogr
B Analyt Technol Biomed Life Sci. 2019; 1124: 161-164.
- Chen XK, Shi HY, Leroux S, Xu HY, Zhou Y, Zheng Y, Huang X, Li Y,
Jacqz-Aigrain E, Zhao W. Penetration of Cefotaxime into Cerebrospinal
Fluid in Neonates and Young Infants. Antimicrob Agents Chemother.
2018; 62: e02448-17.
- Wilson AP. Clinical pharmacokinetics of teicoplanin. Clin
Pharmacokinet. 2000; 39: 167-183.
- Pai MP, Mercier RC, Koster SA. Epidemiology of vancomycin-induced
neutropenia in patients receiving home intravenous infusion therapy.
Ann Pharmacother. 2006; 40: 224-228.
- Farber BF, Moellering RC Jr. Retrospective study of the toxicity of
preparations of vancomycin from 1974 to 1981. Antimicrob Agents
Chemother. 1983; 23: 138-141.
- Morris A, Ward C. High incidence of vancomycin-associated leucopenia
and neutropenia in a cardiothoracic surgical unit. J Infect. 1991; 22:
217-223.
- Smith PF, Birmingham MC, Noskin GA, Meagher AK, Forrest A, Rayner CR,
Schentag JJ. Safety, efficacy and pharmacokinetics of linezolid for
treatment of resistant Gram-positive infections in cancer patients
with neutropenia. Ann Oncol. 2003; 14: 795-801.
- Khoo AL, Zhao YJ, Teng M, Ying D, Jin J, Chee YL, Poon LM, Lim SE, Koh
LP, Chng WJ, Lim BP, Hsu LY, Chai LYA. Evaluation of a risk-guided
strategy for empirical carbapenem use in febrile neutropenia. Int J
Antimicrob Agents. 2018; 52: 350-357.
- Kurtz TO, Winston DJ, Bruckner DA, Martin WJ. Comparative in vitro
synergistic activity of new beta-lactam antimicrobial agents and
amikacin against Pseudomonas aeruginosa and Serratia marcescens.
Antimicrob Agents Chemother. 1981; 20: 139-243.
- Scudamore RA, Goldner M. Penetration of the outer membrane of
Pseudomonas aeruginosa by synergistic combinations of beta-lactam and
aminoglycoside antibiotics. Antimicrob Agents Chemother. 1982; 21:
1007-1010.
- Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ,
Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg
JM, Baltimore RS, Fink AM, O’Gara P, Taubert KA; American Heart
Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki
Disease of the Council on Cardiovascular Disease in the Young, Council
on Clinical Cardiology, Council on Cardiovascular Surgery and
Anesthesia, and Stroke Council. Infective Endocarditis in Adults:
Diagnosis, Antimicrobial Therapy, and Management of Complications: A
Scientific Statement for Healthcare Professionals From the American
Heart Association. Circulation. 2015; 132: 1435-1486.
- Shi R, Zhou Q, Fang R, Xiong X, Wang Q. Severe acute pancreatitis with
blood infection by Candida glabrata complicated severe
agranulocytosis: a case report. BMC Infect Dis. 2018; 18: 706.